Acceptability: total withdrawals · acute mania
It is very uncertain whether lithium changes acceptability: total withdrawals compared with haloperidol (very low certainty).
1 finding from 1 review
Adverse events · acute mania
The review found no eligible studies for this question.
1 finding from 1 review
Lithium for acute mania 2019 · Cochrane Headline outcomes only no estimate extracted
Studies not reported
No studies found
Efficacy: response (categorical) BMRS change ≥ 50% from baseline to end of study · acute mania
It is very uncertain whether lithium changes efficacy: response (categorical) BMRS change ≥ 50% from baseline to… compared with zuclopenthixol (very low certainty).
1 finding from 1 review
Efficacy: response (continuous) change in BPRS (total) from baseline to end of study ‐all data · acute mania
The review found no eligible studies for this question.
1 finding from 1 review
Lithium for acute mania 2019 · Cochrane Headline outcomes only no estimate extracted
Studies not reported
No studies found
Remission · acute mania
The review found no eligible studies for this question.
1 finding from 1 review
Lithium for acute mania 2019 · Cochrane Headline outcomes only no estimate extracted
Studies not reported
No studies found
Adverse event: tremor · acute mania
Lithium leads to higher adverse event: tremor compared with placebo (high certainty).
1 finding from 1 review
Acceptability: total withdrawals · acute mania
It is very uncertain whether lithium changes acceptability: total withdrawals compared with zuclopenthixol (very low certainty).
1 finding from 1 review
Adverse events · acute mania
The review found no eligible studies for this question.
1 finding from 1 review
Lithium for acute mania 2019 · Cochrane Headline outcomes only no estimate extracted
Studies not reported
No studies found
Efficacy: response (categorical) BMRS change ≥ 50% from baseline to end of study · acute mania
The review found no eligible studies for this question.
1 finding from 1 review
Lithium for acute mania 2019 · Cochrane Headline outcomes only no estimate extracted
Studies not reported
No studies found
Efficacy: response (continuous) YMRS/MRS change at the end of the study · acute mania
1 finding from 1 review
Efficacy: remission (categorical) YMRS ≤ 12/absence of DSM‐IV mania by end of study · acute mania
Lithium showed no clear difference in efficacy: remission (categorical) YMRS ≤ 12/absence of DSM‐IV mania… compared with risperidone (low certainty).
1 finding from 1 review
Acceptability: total withdrawals · acute mania
Lithium probably leads to higher acceptability: total withdrawals compared with risperidone (moderate certainty).
1 finding from 1 review
Drowsiness/somnolence (Event rate during treatment, length of treatment varied across trials) · acute mania
Lithium probably leads to lower adverse events: drowsiness/ somnolence compared with risperidone (moderate certainty).
1 finding from 1 review
Efficacy: response (categorical) BMRS change ≥ 50% from baseline to end of study · acute mania
The review found no eligible studies for this question.
1 finding from 1 review
Lithium for acute mania 2019 · Cochrane Headline outcomes only no estimate extracted
Studies not reported
No studies found
Efficacy: response (continuous) YMRS change by ≥ 50% at end of study · acute mania
Lithium showed no clear difference in efficacy: response (continuous) YMRS change by ≥ 50% at end of study compared with aripiprazole (moderate certainty).
1 finding from 1 review
Remission · acute mania
Lithium showed no clear difference in efficacy: remission (categorical) YMRS ≤ 12 at end of study compared with aripiprazole (moderate certainty).
1 finding from 1 review
Somnolence · acute mania
Lithium leads to higher adverse event: somnolence compared with placebo (high certainty).
1 finding from 1 review
Acceptability: total withdrawals · acute mania
Lithium showed no clear difference in acceptability: total withdrawals compared with aripiprazole (moderate certainty).
1 finding from 1 review
Adverse event: tremor · acute mania
Lithium showed no clear difference in adverse events: tremor compared with aripiprazole (moderate certainty).
1 finding from 1 review
Adverse events: somnolence/sedation · acute mania
Lithium showed no clear difference in adverse events: somnolence/sedation compared with aripiprazole (moderate certainty).
1 finding from 1 review